Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice

Abstract

The accumulation of circulating monocytes in the arterial wall is an early event in atherosclerotic plaque formation. Monocyte chemoattractant protein-1 (MCP-1) has been implicated as the primary source of monocyte chemoattractant functioning in these early stages of atherogenesis. To determine whether the receptor for MCP-1, CC chemokine receptor CCR2, plays a role in atherogenesis, CCR2-deficient animals were crossed with mice lacking apo E, a well characterized model of atherosclerosis. While lipid levels were unchanged, the double knockout mice exhibited a 3-fold reduction in mean aortic lesion area compared to apo E-deficient control mice. Furthermore, the lesions in the double mutants were less advanced, consisting primarily of foam cell deposits and fatty streaks located on or directly adjacent to the aortic valve attachment sites. These studies directly demonstrate that the MCP-1 receptor, CCR2, plays an important role in atherogenesis.